Two patients with CTP synthase 1 (CTPS1) deficiency have been treated with third party EBV-specific T cells for EBV-LPD and primary CNS lymphoma, and both had CRs after T cell therapy (14, 23). This evidence concerns the gene CTPS1 and primary central nervous system lymphoma.